Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeRegulatoryDevils Claw is NYAGs Current Supplement Target

Devils Claw is NYAGs Current Supplement Target

<p style="margin: 0in 0in 10pt;">Eric Schneiderman&rsquo;s office said the <i>Harpagophytum zeyheri</i> species of devil&rsquo;s claw is less desirable than <i>Harpagophytum procumbens</i>. The natural products industry disagrees.</p>

The New York Attorney General sent cease-and-desist letters to manufacturers of devil’s Claw supplements, saying DNA barcoding tests revealed that instead of containing the devil’s claw strain Harpagophytum procumbens, it contained the strain Harpagophytum zeyheri.

Schneiderman’s office said the zeyheri species is less desirable. The natural products industry disagrees.

Watch this INSIDER TV news desk to get the industry’s take.

Read more: “New York Attorney General Schneiderman Targets ‘Devil’s Claw’ Supplements”

TAGS: Archive Herbs & Botanicals Supply Chain Labs/Testing
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
Network Insights